Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Pharmacokinetic and Pharmacodynamic Study of the Combination of RO4929097 and Cediranib in Patients With Advanced Solid Tumors

NCT01131234 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01131234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01131234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Pharmacokinetic and Pharmacodynamic Study of the Combination of RO4929097 and Cediranib in Patients With Advanced Solid Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2010
Completion date
September 30, 2014
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adult anaplastic astrocytoma, adult anaplastic ependymoma, adult anaplastic oligodendroglioma, adult brain stem glioma, adult giant cell glioblastoma, adult glioblastoma, adult gliosarcoma, adult mixed glioma, adult solid neoplasm, male breast carcinoma, recurrent adult brain neoplasm, recurrent breast carcinoma, recurrent colon carcinoma, recurrent melanoma, recurrent non-small cell lung carcinoma, recurrent ovarian carcinoma, recurrent ovarian germ cell tumor, recurrent pancreatic carcinoma, recurrent rectal carcinoma, recurrent renal cell carcinoma, stage iii pancreatic cancer, stage iii renal cell cancer, stage iiia colon cancer, stage iiia non-small cell lung cancer, stage iiia ovarian cancer, stage iiia ovarian germ cell tumor, stage iiia rectal cancer, stage iiia skin melanoma, stage iiib breast cancer, stage iiib colon cancer, stage iiib non-small cell lung cancer, stage iiib ovarian cancer, stage iiib ovarian germ cell tumor, stage iiib rectal cancer, stage iiib skin melanoma, stage iiic breast cancer, stage iiic colon cancer, stage iiic ovarian cancer, stage iiic ovarian germ cell tumor, stage iiic rectal cancer, stage iiic skin melanoma, stage iv breast cancer, stage iv non-small cell lung cancer, stage iv ovarian cancer, stage iv ovarian germ cell tumor, stage iv pancreatic cancer, stage iv renal cell cancer, stage iv skin melanoma, stage iva colon cancer, stage iva rectal cancer, stage ivb colon cancer, stage ivb rectal cancer